作者: Jean Baptiste Bachet , Olivier Lucidarme , Julien Taïeb , Emilie Maillard , Charles-Briac Levache
DOI: 10.1200/JCO.2016.34.15_SUPPL.3513
关键词: Colorectal cancer 、 Oncology 、 Medicine 、 Front line 、 Internal medicine 、 Disease 、 In patient 、 Primary tumor 、 FOLFIRINOX 、 Therapeutic strategy 、 Surgery 、 INDUCTION TREATMENT
摘要: 3513Background: Optimal therapeutic strategy in patients (pts) with RCSM remains discussed and many front line options can be to best treat primary tumor metastatic disease: surgery (...